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Abstract 
Review on t(4;11)(q23;p15) NUP98/RAP1GDS1, 
with data on clinics. 
Identity 
The t(4;11)(q23;q15) is a rare but recurrent 
translocation strongly associated with T-cell acute 
lymphoblastic leukemia (T-ALL). This translocation 
results in a novel gene fusion of NUP98/11p15 and 
RAP1GDS1/4q23 genes [Figure 1]. Therefore, 
t(4;11)(q23;p15) is NOT a variant of the 
t(4;11)(q21;q23) involving the AFF1 and KMT2A 
(MLL) genes, as previously presumed. 
Clinics and pathology 
Disease 
The t(4;11)(q23;p15) is mostly described in an early 
precursor T-cell ALL of thymic origin. Only two 
cases with acute myeloid leukemia (AML) were 
reported with this translocation; the 
t(4;11)(q?13;p15) with NUP98/RAP1GDS1 fusion 
expression was identified in a patient with AML-M0 
at time of diagnosis. Whereas the second case was 
with AML-M4, in which the t(4;11)(q23;p15) was 
detected at relapse with a normal karyotype at 
diagnosis. 
Phenotype/cell stem origin 
Bone marrows are hypercellular with a massive 
infiltration (~90%) with lymphoblasts of L1 or L2 
morphology. Whereas different markers are tested  
for each case, leukemic cells are generally positive 
for CD3, CD5, CD7, CD10, TdT, and thymic 
associated marker CD1a, negative or partially 
expressing CD2, CD4, and CD8.  One or more 
myeloid markers CD11b, CD13, and/or CD33 are 
co-expressed in some patients. This suggests that 
NUP98/RAP1GDS1 fusion occurs in subset of T-
ALL originated from an early progenitor with a 
potential to express mature T-cell antigens as well as 
myeloid markers. 
Epidemiology 
Patient's ages are ranged from 6 to 60 years, with a 
predominance of younger individuals (60% < = 25 
years) as is classic for T-cell ALL. None of the 
patients with this translocation was an infant. The 
t(4;11)(q23;p15) seems to be extremely rare and its 
exact incidence in leukemia is difficult to establish. 
In large studies, t(4;11) was identified in 
approximately 2% adult and in 0.3% children with 
T-ALL while other studies have failed to detect a 
single case. 
Clinics 
Most patients present with a high WBC counts with 
a high proportion of blasts, generalized 
lymphadenopathy and mediastinal mass but 
hepatospenomagaly is less frequent. 
Prognosis 
The risk associated with t(4;11)(q23;p15.4) is not 
well determined due to low number of cases 
although most patients with this translocation had a 
short survival. 
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Figure 1; Left; Partial karyotype showing t(4;11)(q23;p15), Right; FISH showing a double fusion pattern of NUP98-RAP1GDS1 
genes.  
 
Cytogenetics 
Karyotype is relatively simple with t(4;11)(q23;p15) 
a sole abnormality in 5/13 cases (Table 1). 
Cytogenetics morphological 
See Table 1.  
 
 
Additional anomalies 
One or two additional abnormalities were seen in 
8/13 cases including del(12p) in two cases; del(5q), 
del(9p) , del(13q) , or  trisomy 8 in a single case each. 
Variants 
t(1;4;11)(p32;q21;p15) was reported in one case. 
 
 
Patient Leukemia 
Age/
Sex 
WBC 
109/L 
Karyotype Fusion Genes Outcome References 
1 T-ALL L1 21/M 423 
46,XY,t(4;11)(q21;p15),+2m
ar  
NUP98/RAP1GDS1 
Relapsed after 
2 matched 
BMT; died 43 
M 
Hussey et 
al., 1999 
2 T-ALL L1 25/F 1.8 
46,XX,t(4;11)(q21;p14-15), 
del(12)(p13),+del(13)(q12q1
4)  
NUP98/RAP1GDS1 
Failure of 
induction; 
Died 1M later 
Hussey et 
al., 1999 
3 T-ALL L2 49/M 169 
46,XY,t(4;11)(q21;p15),del(
5)(q13q31)  
NUP98/RAP1GDS1 
BM 
remission, 
early relapse, 
died 14 M 
Hussey et 
al., 1999 
4 T-ALL L2 16/F 34 47,XX,t(4;11)(q21;p15),+8  NUP98/RAP1GDS1 
CR, followed 
by BMT; 7 
m+ 
Mecucci et 
al., 2000 
5 T-ALL L2 38F 35 
47,XX,t(4;11)(q21;p15),+ma
r  
NUP98/RAP1GDS1 
CR, relapsed 
in 8 m; died 
after  BMT  
Mecucci et 
al. 2000 
6 AML-M0 60/F 3.9 
46- 
t(4;11)(q1?3;p15),?der(8)(p?) 
NUP98/RAP1GDS1 
CR; relapsed 
and died 8m 
after 
diagnosis 
van Zutven 
et al, 2006 
7 T-ALL 15/M 72.8 
46,XY,t(4;11)(q23;p15),del(
9)(p13) 
NUP98/RAP1GDS1 
CR obtained, 
survival 7M+ 
Present case, 
2015 
Table 1: Reported acute leukemia cases with t(4;11)(q21-q23;p15) and NUP98/RAP1GDS1 gene fusion. 
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Genes involved and 
proteins 
RAP1GDS1 (RAP1, GTP-GDP 
dissociation stimulator 1) 
Location 
4q23 
DNA/RNA 
RAP1, GTP-GDP dissociation stimulator 1 
(RAP1GDS1) is a gene that encodes a protein that 
functions as a stimulatory GDP/GTP exchange 
protein with GTPase activity. Fusions, missense 
mutations, nonsense mutations, silent mutations, 
frameshift deletions, and in-frame deletions are 
observed in cancers such as endometrial cancer , 
intestinal cancer, and skin cancer . 
Protein 
RAP1GDS1 encodes a 558-amino acid protein with 
a molecular mass of 61.1 kD. The product of the 
RAP1GDS1 gene, usually referred to as smgGDS, 
has guanine nucleotide exchange factor activity. It 
stimulates the conversion of inactive GDP-bound 
from small GTPases to the active GTP-bound form. 
It has been speculated that smgGDS might also play 
a role in nucleocytoplasmic transport, as smgGDS is 
composed of multiple armadillo repeats that are 
thought to mediate protein-protein interactions.  
SmgGDS has been described as a "master regulator" 
of small GTPases, such as RHOA , RAC1 , RAP1A 
, RAP1B , and KRAS . SmgGDS controls the 
activities of these GTPases through several 
mechanisms, most notably by controlling their 
prenylation and trafficking to cell membranes. The 
ability of smgGDS to regulate the cell cycle in 
multiple cancer cell lines with different mutational 
profiles indicates the importance of this protein as a 
key regulator of malignancy. SmgGDS is 
overexpressed in multiple types of cancer, including 
non-small cell lung carcinoma , prostate cancer , 
pancreatic cancer  and breast cancer , making 
SmgGDS is an attractive target for cancer 
therapeutics. 
NUP98 (nucleoporin 98 kDa) 
Location 
11p15.4 
DNA/RNA 
NUP98 is one of several genes located in the 
imprinted gene domain of chromosome 11p15.  
Combined haploinsufficiency of NUP98 and RAE1 
has been shown to result in premature separation of 
sister chromatids, leading to severe aneuploidy. 
NUP98 plays roles in gene expression, mitotic 
spindle formation, and cell cycle progression.  
NUP98 gene is fused to a large number of "partner 
genes" caused primarily by balanced translocations 
and inversions which are associated with a wide 
variety of hematological malignancies including 
AML and MDS (de novo and therapy related), CML-
blast crisis, and pre T- ALL. To date, no NUP98 
fusion gene has been described in B-cell 
malignancies. At least 30 different partner genes are 
reported to fuse with NUP98; 50% of which are 
homeobox genes. Approximately 10% of patients 
with NUP98 fusions have T-ALL; most commonly, 
these malignancies are associated with NUP98-
RAP1GDS1 gene fusions.  This suggests that 
different partner genes are associated with different 
leukemia, although such associations are rarely 
exclusive. Although NUP98 breakpoints in these 
translocations are variable located between introns 9 
to 14, a chimeric transcript consisting of the 5' 
portion of NUP98 fused in-frame to the 3' portion of 
the partner genes is generated in all. 
Protein 
NUP98 gene encodes two alternatively spliced 
mRNA variants: NUP98 and NUP98-NUP96 that 
are cleaved to produce two distinct nucleoporins, 
NUP98 and NUP96. The NUP98 is a 98 kDa protein 
component of the nuclear pore complex (NPC) 
family which is involved in the trafficking of RNA 
and protein between the nucleus and cytoplasm. The 
NUP98 protein contains two partially characterized 
functional domains: a GLFG repeat region, which 
serves as a nuclear transport receptor docking 
surface, and a GLEBS domain, which mediates the 
interaction with the RAE1 mRNA nuclear export 
factor. Both domains are located within the N-
terminal portion of NUP98.  The chimeric NUP98 
protein that results from translocations always 
retains the intact N-terminal GLFG repeats of 
NUP98 and the C-terminal domain of the partner 
protein. NUP96 is a scaffold component of the NPC. 
Result of the chromosomal 
anomaly 
Hybrid gene 
Of the 13 cases reported in the literature with 
t(4;11)(q23;q15); seven cases showed  
NUP98/RAP1GDS1 gene fusion while the status of 
these genes were not tested in the remaining five 
cases (Table 1). 
Fusion protein 
Description 
T(4;11) generates two reciprocal chimeric products; 
chimeric 5'NUP98 -3'RAP1GDS1 transcript 
produces a novel protein composed of the N-
terminal portion of the NUP98 protein and the entire 
smgGDS which is anticipated to promote 
leukemogenesis.  However, the reciprocal 5' 
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RAP1GDS1-3'NUP98 transcript is often but not 
always expressed. 
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